Interventional procedures in whole organ and islet cell pancreas transplantation

Seminars in Interventional Radiology

Volumn 21, Issue 4, 2004, Pages 335-343

  Daly, Barry ^a,b   O'Kelly, Kevin ^c   Klassen, David ^d  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Islet cell pancreas transplantation; Percutaneous intervention; Whole organ pancreas transplantation

Indexed keywords

ANGIOGRAPHY; BIOPSY TECHNIQUE; CELL ISOLATION; CELL TRANSFER; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; ECHOGRAPHY; HUMAN; INJECTION; INTERVENTIONAL RADIOLOGY; ORGAN TRANSPLANTATION; PANCREAS BIOPSY; PANCREAS CELL; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN; RADIOLOGIST; REVIEW; SURGICAL DRAINAGE; SURGICAL TECHNIQUE;

EID: 11344280152     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-861568     Document Type: Review

References (31)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
2. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study. II. Cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999;16:466-471
3. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learnt from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001;233:463-501
4. Marks WH, Borgstrom A, Marks CR, Sollinger H, Lorber MI. Serum markers for pancreas rejection: long-term behavior following clinical pancreatico-duodenal transplantation. Transplant Proc 1991;23:1596-1597
5. Perkal M, Marks C, Lorber MI, Marks WH. A three-year experience with serum anodal trypsinogen as a biochemical marker for rejection in pancreatic allografts. False positives, tissue biopsy, comparison with other markers, and diagnostic strategies. Transplantation 1992;53:415-419
6. Klassen DK, Weir MR, Cangro CB, Bartlett ST, Papadimitriou JC, Drachenberg CB. Pancreas allograft biopsy: safety of percutaneous biopsy-results of a large experience. Transplantation 2002;73:553-555
7. Warnock GL, Kneteman NM, Ryan EA, Seelis REA, Rabinovitch A, Rajotte RV. Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 diabetes. Diabetologia 1991;34:55-58
8. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppression regimen. N Engl J Med 2000;343:230-238
9. Allen RD, Wilson TG, Grierson JM, et al. Percutaneous biopsy of bladder-drained pancreas transplants. Transplantation 1991;51:1213-1216
10. Douzdjian V, Cooper J, Abecassis M, Corry R. Markers for pancreatic allograft rejection: comparison of serum anodal trypsinogen amylase, serum creatinine and urinary amylase. Clin Transplant 1994;8:79-82
11. Wong JJ, Krebs TL, Klassen DK, et al. Sonographic evaluation of acute pancreatic transplant rejection: morphology-Doppler analysis versus guided percutaneous biopsy. AJR Am J Roentgenol 1996;166:803-807
12. Krebs TL, Daly B, Wong-You-Cheong JJ, Carroll K, Bartlett ST. Acute pancreatic transplant rejection: evaluation with dynamic contrast-enhanced MR imaging compared with histopathologic analysis. Radiology 1999;210:437-442
13. Klassen DK, Hoen-Saric EW, Weir MR, et al. Isolated pancreas rejection in combined kidney pancreas tranplantation. Transplantation 1996;61:974-977
14. Bartlett ST, Schweitzer EJ, Johnson LB, et al. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. Ann Surg 1996;224:440-449
15. Laftavi MR, Gruessner AC, Bland BJ, et al. Diagnosis of pancreas rejection: cystoscopic transduodenal versus percutaneous computed tomography scan-guided biopsy. Transplantation 1998;65:528-532
16. Atwell T, Gorman B, Larson T, et al. Pancreas Transplants: Experience with 232 percutaneous US-guided biopsy procedures in 88 patients. Radiology 2004;231:845-849
17. Drachenberg CB, Papadimitriou JC, Klassen DK, et al. Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system. Transplantation 1997;63:1579-1586
18. Drachenberg CB, Klassen DK, Weir MR, et al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999;68:396-402
19. Papadimitriou JC, Drachenberg CB, Klassen DK, et al. Histological grading of chronic pancreas allograft rejection/graft sclerosis. Am J Transplant 2003;3:599-605
20. Drachenberg CB, Abruzzo LV, Klassen DK, et al. Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection. Hum Pathol 1998;29:569-577
21. Klassen DK, Drachenberg CB, Papadimitriou JC, et al. CMV allograft pancreatitis: diagnosis, treatment, and histological features. Transplantation 2000;69:1968-1971
22. Aideyan OA, Schmidt AJ, Trenkner SW, Hakim NS, Gruessner RW, Walsh JW. CT-guided percutaneous biopsy of pancreas transplants. Radiology 1996;201:825-828
23. Krebs T, Wong-You-Cheong J, Daly B. Pancreatic transplantation imaging. In: Gore RM, Levine MS, eds. Textbook of Gastrointestinal Radiology. 2nd ed. Philadelphia: WB Saunders; 2000
24. Letourneau JG, Hunter DW, Crass JR, Thompson WM, Sutherland DE. Percutaneous aspiration and drainage of abdominal fluid collections after pancreatic transplantation. AJR Am J Roentgenol 1988;150:805-809
25. Patel BK, Garvin PJ, Aridge DL, Chenoweth JL, Markivee CR. Fluid collections developing after pancreatic transplantation: radiologic evaluation and intervention. Radiology 1991;181:215-220
26. Norstein J, Brekke IB, Holdaas H, Vatne K. Arterial stenoses in duct occluded segmental pancreatic grafts treated with percutaneous transluminal angioplasty. Transplant Proc 1990;22:599-601
27. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001;88(7):165-175
28. Owen JT, Ryan EA, O'Kelly K, et al. Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology 2003;229:165-170
29. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical Outcomes and Insulin Secretion after Islet Transplantation with the Edmonton Protocol. Diabetes 2001;50(4):710-719
30. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppression regimen. N Engl J Med 2000;343:230-238
31. Bucher P, Mathe Z, Bosco D, et al. Morbidity Associated With Intraportal Islet Cell Transplantation. Proceedings of IPITA Congress Dublin; 2003(Published on-line). (www.ipita.org/abstracts/2003_060_066.htm)